Proximal aortic perforation after endovascular repair of a type B dissection in a patient with Marfan syndrome  by van Keulen, Jasper W. et al.
Proximal aortic perforation after endovascular
repair of a type B dissection in a patient with
Marfan syndrome
Jasper W. van Keulen, MD, Frans L. Moll, MD, PhD, A. Khodadade Jahrome, MD, and
Joost A. van Herwaarden, MD, PhD, Utrecht, The Netherlands
Several successful cases of endovascular treatment of type B dissections in patients with Marfan syndrome have been
reported. In our patient with Marfan syndrome, a type B dissection was successfully treated endovascularly. Three weeks
after this procedure, a computed tomographic angiography (CTA) revealed a perforation of the aortic wall distal to the
left subclavian artery by a bare strut of the stent graft. A second stent graft was placed to treat this complication. In
patients with Marfan syndrome, complications might be prevented by using stent grafts specifically developed to treat
dissections. However, specific complications, eg, perforation, must be taken into account and patients have to be followed
attentively. ( J Vasc Surg 2009;50:190-2.)Marfan syndrome is an autosomal dominant connective
tissue disorder that typically involves the cardiovascular,
skeletal, and ocular systems. This genetic disorder is caused
by mutations on the fibrillin gene, located on chromosome
15q. Vascular abnormalities, notably aortic dilation and
dissection, are the most life-threatening manifestations of
Marfan syndrome.1 Recently, several technically successful
and uneventful endovascular treatments of aortic dissec-
tions in patients with Marfan syndrome have been repor-
ted.2-4 However, according to the instructions for use of
stent grafts, patients with connective tissue disorders are
not suitable for endovascular repair. We present a case
wherein endovascular repair of a type B dissection in a
patient withMarfan syndrome is complicated by a proximal
strut perforation through the aortic wall.
CASE REPORT
A 55-year-old male, in 1992 diagnosed to have Marfan syn-
drome, presented with acute onset of severe back-pain, especially
between his shoulders. A computed tomographic angiography scan
(CTA) revealed a type B aortic dissection: the intimal flap originated
just distal to the origin of the left subclavian artery and extended into
the right iliac artery (Fig 1). A first entry site between the true and false
lumen was seen 10 cm distal to the left subclavian artery (LSCA), a
second12 cmdistal to theLSCA.The aorta proximal to the dissection
had a diameter of 29 mm. The maximum diameter of the thoracic
aorta was 40 mm (True lumen 22 mm), while the abdominal aorta
had a maximum diameter of 37 mm (True lumen 17 mm). No
stenoses were seen in the vertebral and carotid arteries.
Since the patient was hemodynamically stable, conservative
treatment was started to decrease the systolic blood pressure
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190below 130 mm Hg (analgesics, Acetaminophen and Adolan,
and a combination of three anti-hypertensive agents, Triam-
terene, Perindopril, Metoprolol, were given. Metroprolol was
exchanged for Labetalol hydrochloride after several days).
Six days after admission, the patient became hemodynamically
unstable and the back-pain aggravated. On CTA, a rupture of the
dissection in the descending thoracic aorta was seen. Therefore,
the dissection entry points were excluded with two Valiant stent
graft segments (Medtronic, Minneapolis, Minn); Proximal stent
graft: diameter of 34 mm; length of 200 mm. Distal stent graft:
diameter of 36mm; length of 150mm. The stent graft was inserted
via the left femoral artery, and angiography was performed via the
right brachial artery. Stent graft type and sizing was not considered
ideal: we had preferred to use a less oversized non-bare stent graft.
However, in the acute setting, such a stent graft was unavailable in
our hospital. We deployed the stent graft just below the LSCA
since the stent graft diameter was considered too big to overstent
the LSCA. Besides, the most proximal detected entry was seen 10
cm below the LSCA. We decided to overstent the aorta with two
stent graft segments to be sure that also possibly undetected entry
sites were overstented. A spinal drainage device was placed direct
postoperatively.
Postprocedural CTA showed closure of the intimal tear
(Fig 2, A). Three weeks after the procedure, the back pain
suddenly increased and a CTA was made, revealing a proximal
pseudoaneurysm caused by a perforation of a proximal bare strut of
the stent through the vessel wall (Fig 2, B).
The pseudoaneurysm was treated by endovascular placement
of an extra stent, a Relay non-bare stent, 32 mm in diameter and
164 mm long (Bolton medical, Sunrise, Fla) (Insertion via the left
femoral artery, angiography via the right brachial artery). The size
of this stent graft was based on measurements proximal to the
LSCA.
The periprocedural angiography confirmed the perforation
(Fig 3). The Relay none-bare stent, which is especially designed for
treatment of dissections, was placed between the left common
carotid artery and the LSCA. A spinal drainage device was placed
preoperatively. We did not revascularize the LSCA in this proce-
dure primarily since we expected the risk onmyelum ischemia to be
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severe atherosclerosis. A postprocedural CTA showed exclusion of
the pseudoaneurysm (Fig 4).
After the reintervention, the back pain had disappeared.
Fig 1. Computed tomographic angiography (CTA) of the tho-
racic aorta showing a type B dissection, sagittal view.
Fig 2. A, Computed tomographic angiography (CTA) performed
after the first procedure, sagittal view. Successful closure of the pri-
mary intimal tear was seen. B, CTA performed 3 weeks after the first
procedure, sagittal view. A proximal pseudoaneurysm, based on per-
foration of a proximal bare strut through the aortic wall, was seen.Four days after the second intervention, there were no moremedical indications to keep the patient in the hospital. How-
ever, the patient was not dismissed out of the hospital until 20
days after the second intervention since no domiciliary care was
available. Until now, 110 days after the second operation, no
new complications have occurred and CTA reveals no abnor-
Fig 3. Angiography performed before deployment of the
second stent graft. Note the obvious dislocation of the first
stent graft with perforation of the aortic wall and contrast
extravasation.
Fig 4. Computed tomographic angiography (CTA) of the tho-
racic aorta with three-dimensional volumetric reconstruction that
shows successful exclusion of the pseudoaneurysm.malities (Fig 4).
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Complicated type B dissection in patients with Marfan
syndrome requires surgical intervention.5 However, con-
ventional surgery for descending aortic dissection is unfa-
vorable in patients with substantial comorbidity, and has a
high mortality rate, ranging from 8 % to 57%.6 An alterna-
tive to open repair is endovascular treatment, which is
feasible and can be technically successful in patients with
Marfan syndrome.3 Although safe stent graft placements in
patients with Marfan syndrome are published, evidence of
long-term success is missing, due to the small number of
published cases and limited follow-up.4 In addition, publi-
cation bias has probably led to under-reporting of less
successful cases. Next to this, it was stated in the 2008
expert consensus that endovascular repair in patients with
Marfan syndrome is not recommended unless operative
intervention is clearly indicated and the risk of conventional
repair is deemed prohibitive.7
Although the placement of a stent graft can be techni-
cally successful, Marfan syndrome patients are intuitively
more prone to several specific complications after endovas-
cular repair. Aortic dilation, which frequently occurs in
patients with Marfan syndrome,1 may be manifest around
fixation and sealing points of the endograft allowing for
subsequent stent graft migration or periprosthetic leaks.
Next to this, the mutation in the fibrillin gene in patients
with Marfan syndrome results in weakened soft tissue,
which thus makes the aortic wall more fragile. Therefore,
the aortic wall may not withstand the pressure of the stent
graft, with perforation as consequence. To the best of our
knowledge, this is the first report on a perforation of the
aortic wall by a stent graft in a patient with Marfan syn-
drome.
To prevent complications, we believe that endovascular
treatment of aortic dissections requires specific types of
stent grafts. Flexibility and radial expansion characteristics
of stent grafts used for treatment of aortic dissections
should be different than those used for treatment of aortic
aneurysms. With treatment of aneurysms, a high localized
radial force is essential at the relative short proximal and
distal landing zones. With dissections, however, the stent
graft most commonly has apposition over its entire length:
less proximal and distal radial force is probably needed.
Besides, the fragile aortic wall in patients with dissections,
and especially in patients with Marfan syndrome, could be
easily injured by bare struts and high radial force. This has
led to our assumption that endografts with non-bare struts
are preferable in patients with a dissection. Next to the use
of stent grafts specifically designed to treat dissections, weadvise to oversize stent grafts about 5% in patients with a
dissection. More oversizing of stent grafts increases radial
force, and the struts might perforate the fragile aortic wall.
Retrospectively, it is not unimaginable that the perfo-
ration of the bare strut through the aorta could have been
prevented in this case. Overstenting of only the proximal
entry site leads to a vulnerable stent graft landing zone: the
aortic wall of a Marfan syndrome patient even weakened by
a dissection. Therefore, we believe that overstenting of the
entire initial dissection is possibly a better method than just
overstenting the proximal entry site between the true and
false lumen in patients with a connective tissue disease.
In the follow-up of Marfan patients after endovascular
exclusion of a type B dissection, we recommend to perform
CTAs regularly: within a few days postoperative, after 3 and
9 months, and thereafter yearly.
In conclusion, endovascular treatment of type B dissec-
tions in patients with Marfan syndrome should only be
considered when operative intervention is clearly indicated,
eg, in case of rupture. The risks on complications in patients
with Marfan syndrome after endovascular treatment might
be lowered by the use of (non-bare) stent grafts specifically
developed to treat dissections. Moreover, Marfan syn-
drome patients who are treated endovascularly have to be
monitored closely. Specific complications in patients with
Marfan syndrome after endovascular repair of a type B
dissection must be taken into account to permit, if neces-
sary, early reintervention.
The authors thank Joffrey van Prehn, MD, and Gert J.
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